Biotechnology in Asia-Pacific

Biotechnology in Asia-Pacific industry profile provides top-line qualitative and quantitative summary information including: market size (value 2010-14, and forecast to 2019). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market. Essential resource for top-line data and analysis covering the Asia-Pacific biotechnology market. Includes market size data, textual and graphical analysis of market growth trends, leading companies and macroeconomic information.

The biotechnology industry consists of the development, manufacturing, and industrying of products based on advanced biotechnology research.

The Asia-Pacific biotechnology industry had total revenues of $77.4bn in 2014, representing a compound annual growth rate (CAGR) of 6.8% between 2010 and 2014.

The medical/healthcare segment was the industry's most lucrative in 2014, with total revenues of $40.1bn, equivalent to 51.8% of the industry's overall value.

The performance of the industry is forecast to decelerate, with an anticipated CAGR of 5.1% for the five-year period 2014 – 2019, which is expected to drive the industry to a value of $99.1bn by the end of 2019.

Scope

Save time carrying out entry-level research by identifying the size, growth, and leading players in the biotechnology market in Asia-Pacific

Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the biotechnology market in Asia-Pacific

Leading company profiles reveal details of key biotechnology market players’ global operations and financial performance

Add weight to presentations and pitches by understanding the future growth prospects of the Asia-Pacific biotechnology market with five year forecasts

Macroeconomic indicators provide insight into general trends within the Asia-Pacific economy

Reasons to buy

What was the size of the Asia-Pacific biotechnology market by value in 2014?

What will be the size of the Asia-Pacific biotechnology market in 2019?

What factors are affecting the strength of competition in the Asia-Pacific biotechnology market?

How has the market performed over the last five years?

Companies mentioned

Astellas Pharma Inc., Merck & Co., Inc., Mitsubishi Tanabe Pharma Corporation and Takeda Pharmaceutical Company Limited

Table of Contents

TABLE OF CONTENTS

Executive Summary 2

Market value 2

Market value forecast 2

Category segmentation 2

Geography segmentation 2

Market rivalry 2

Market Overview 7

Market definition 7

Market analysis 7

Market Data 8

Market value 8

Market Segmentation 9

Category segmentation 9

Geography segmentation 10

Market Outlook 11

Market value forecast 11

Five Forces Analysis 12

Summary 12

Buyer power 13

Supplier power 14

New entrants 15

Threat of substitutes 17

Degree of rivalry 18

Leading Companies 19

Astellas Pharma Inc. 19

Merck & Co., Inc. 22

Mitsubishi Tanabe Pharma Corporation 25

Takeda Pharmaceutical Company Limited 28

Methodology 31

Industry associations 32

Related MarketLine research 32

Appendix 33

About MarketLine 33

LIST OF TABLES

Table 1: Asia-Pacific biotechnology industry value: $ billion, 201014(e) 8

Table 2: AsiaPacific biotechnology industry category segmentation: $ billion, 2014(e) 9

Table 3: AsiaPacific biotechnology industry geography segmentation: $ billion, 2014(e) 10

Table 4: Asia-Pacific biotechnology industry value forecast: $ billion, 201419 11

Table 5: Astellas Pharma Inc.: key facts 19

Table 6: Astellas Pharma Inc.: key financials ($) 20

Table 7: Astellas Pharma Inc.: key financials (Â¥) 20

Table 8: Astellas Pharma Inc.: key financial ratios 20

Table 9: Merck & Co., Inc.: key facts 22

Table 10: Merck & Co., Inc.: key financials ($) 23

Table 11: Merck & Co., Inc.: key financial ratios 23

Table 12: Mitsubishi Tanabe Pharma Corporation: key facts 25

Table 13: Mitsubishi Tanabe Pharma Corporation: key financials ($) 26

Table 14: Mitsubishi Tanabe Pharma Corporation: key financials (Â¥) 26

Table 15: Mitsubishi Tanabe Pharma Corporation: key financial ratios 26

Table 16: Takeda Pharmaceutical Company Limited: key facts 28

Table 17: Takeda Pharmaceutical Company Limited: key financials ($) 28

Table 18: Takeda Pharmaceutical Company Limited: key financials (Â¥) 29

Table 19: Takeda Pharmaceutical Company Limited: key financial ratios 29

LIST OF FIGURES

Figure 1: Asia-Pacific biotechnology industry value: $ billion, 201014(e) 8

Figure 2: AsiaPacific biotechnology industry category segmentation: % share, by value, 2014(e) 9

Figure 3: AsiaPacific biotechnology industry geography segmentation: % share, by value, 2014(e) 10

Figure 4: Asia-Pacific biotechnology industry value forecast: $ billion, 201419 11

Figure 5: Forces driving competition in the biotechnology industry in Asia-Pacific, 2014 12

Figure 6: Drivers of buyer power in the biotechnology industry in Asia-Pacific, 2014 13

Figure 7: Drivers of supplier power in the biotechnology industry in Asia-Pacific, 2014 14

Figure 8: Factors influencing the likelihood of new entrants in the biotechnology industry in Asia-Pacific, 2014 15

Figure 9: Factors influencing the threat of substitutes in the biotechnology industry in Asia-Pacific, 2014 17

Figure 10: Drivers of degree of rivalry in the biotechnology industry in Asia-Pacific, 2014 18

Figure 11: Astellas Pharma Inc.: revenues & profitability 21

Figure 12: Astellas Pharma Inc.: assets & liabilities 21

Figure 13: Merck & Co., Inc.: revenues & profitability 23

Figure 14: Merck & Co., Inc.: assets & liabilities 24

Figure 15: Mitsubishi Tanabe Pharma Corporation: revenues & profitability 27

Figure 16: Mitsubishi Tanabe Pharma Corporation: assets & liabilities 27

Figure 17: Takeda Pharmaceutical Company Limited: revenues & profitability 29

Figure 18: Takeda Pharmaceutical Company Limited: assets & liabilities 30

List of Tables

NA

List of Figures

NA

    Pricing

Discounts available for multiple report purchases.

reportstore@marketline.com
+44 (0) 161 359 5817

Saved reports